Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ADAMAS PHARMACEUTICALS, INC.

(ADMS)
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Drifting Monday as Biotechs Climb

10/11/2021 | 01:25pm EST


ę MT Newswires 2021
All news about ADAMAS PHARMACEUTICALS, INC.
11/24ADAMAS PHARMACEUTICALS : Completion of Acquisition or Disposition of Assets - Form 8-K
PU
11/24ADAMAS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of..
AQ
11/24Adamas Pharmaceuticals, Inc. Announces Management Changes
CI
11/24ADAMAS PHARMACEUTICALS, INC.(NASDAQG : ADMS) dropped from S&P Global BMI Index
CI
11/24ADAMAS PHARMACEUTICALS, INC.(NASDAQG : ADMS) dropped from S&P TMI Index
CI
11/24ADAMAS PHARMACEUTICALS, INC.(NASDAQG : ADMS) dropped from NASDAQ Composite Index
CI
11/23Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for A..
AQ
11/17Northland Downgrades Adamas Pharmaceuticals to Market Perform From Outperform; Price Ta..
MT
11/11ADAMAS : Q3 Earnings Snapshot
AQ
11/10ADAMAS PHARMACEUTICALS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
AQ
More news
Analyst Recommendations on ADAMAS PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2020 74,5 M - -
Net income 2020 -57,4 M - -
Net Debt 2020 54,9 M - -
P/E ratio 2020 -2,14x
Yield 2020 -
Capitalization 376 M 376 M -
EV / Sales 2019 2,02x
EV / Sales 2020 2,40x
Nbr of Employees 138
Free-Float 99,3%
Chart ADAMAS PHARMACEUTICALS, INC.
Duration : Period :
Adamas Pharmaceuticals, Inc. Technical Analysis Chart | ADMS | US00548A1060 | MarketScreener
Technical analysis trends ADAMAS PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers and Directors
Neil F. McFarlane Chief Executive Officer & Director
Christopher B. Prentiss Chief Financial Officer
David L. Mahoney Non-Executive Chairman
Adrian Quartel Chief Medical Officer
William W. Ericson Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ADAMAS PHARMACEUTICALS, INC.89.84%376
MODERNA, INC.237.35%142 893
LONZA GROUP AG30.63%59 859
IQVIA HOLDINGS INC.44.63%49 504
SEAGEN INC.-8.64%29 257
CELLTRION, INC.-42.34%23 827